About PhRMA
The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country’s leading innovative biopharmaceutical research companies, which are laser focused on developing innovative medicines that transform lives and create a healthier world. Together, we are fighting for solutions to ensure patients can access and afford medicines that prevent, treat and cure disease. Over the last decade, PhRMA member companies have invested more than $850 billion in the search for new treatments and cures, and they support nearly five million jobs in the United States.
Connect with PhRMA
For information on how innovative medicines save lives, please visit:
www.PhRMA.org
www.VotersforCures.org
www.AmericasMedicines.com
www.Facebook.com/PhRMA
www.X.com/PhRMA
BsUFA III will play a critical role in improving the predictable, timely and efficient development and regulatory review of biosimilar and interchangeable biosimilar products. PhRMA fully supports both the proposed BsUFA III performance goals as well as a timely legislative reauthorization of BsUFA. PhRMA looks forward to working with FDA, Congress, patient and medical provider groups and other stakeholders to ensure timely reauthorization of this important program and that there are no disruptions to the FDA activities.
BsUFA III PhRMA Priorities image
Report
Intellectual Property
BsUFA III PhRMA Priorities
BsUFA III PhRMA Priorities image